PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-15
DOI
10.1007/s00259-019-04601-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus
- (2019) Lisa Bodei et al. JOURNAL OF NUCLEAR MEDICINE
- NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
- (2019) Anna Malczewska et al. Endocrine Connections
- Assessment of NETest Clinical Utility in a U.S. Registry‐Based Study
- (2018) Eric Liu et al. ONCOLOGIST
- Blood mRNA Measurement (NETest) for Neuroendocrine Tumors diagnosis of Image-negative liver metastatic disease
- (2018) Anna Malczewska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
- (2018) Mark J. C. van Treijen et al. Frontiers in Endocrinology
- Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [ 177 Lu-DOTA 0 ,Tyr 3 ]octreotate
- (2017) Tessa Brabander et al. ENDOCRINE-RELATED CANCER
- Therapy: The role of liquid biopsies to manage and predict PRRT for NETs
- (2017) Mark Kidd et al. Nature Reviews Gastroenterology & Hepatology
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
- (2016) Shahil Amin et al. BMC CANCER
- Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
- (2016) Dik J. Kwekkeboom et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive
- (2016) Marianne Pavel et al. NEUROENDOCRINOLOGY
- Chromogranin A
- (2016) Mark Kidd et al. Current Opinion in Endocrinology Diabetes and Obesity
- Biomarkers in Pharmaceutical Research
- (2015) X. Zhao et al. CLINICAL CHEMISTRY
- Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status
- (2015) Mark Kidd et al. ENDOCRINE-RELATED CANCER
- Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
- (2015) L. Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
- (2015) Jarosław B. Ćwikła et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Consensus on biomarkers for neuroendocrine tumour disease
- (2015) Kjell Oberg et al. LANCET ONCOLOGY
- Oncotype DX® colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence
- (2015) Y. Nancy You et al. SURGICAL ONCOLOGY-OXFORD
- Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2014) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
- (2013) Irvin M. Modlin et al. PLoS One
- Does the Pretherapeutic Tumor SUV in 68Ga DOTATOC PET Predict the Absorbed Dose of 177Lu Octreotate?
- (2012) Samer Ezziddin et al. CLINICAL NUCLEAR MEDICINE
- Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs)
- (2012) Kjell Öberg Theranostics
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
- (2011) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
- (2010) A. R. Haug et al. JOURNAL OF NUCLEAR MEDICINE
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now